Table 1.
Periprosthetic Joint Infection. Details and Treatment.
| Patients (n = 19) |
UKA side | Time from Primary UKA to DAIR (days) | CRP (mg/L) | Organism(s) | Follow-up (months) | Antibiotic(s) administered |
|---|---|---|---|---|---|---|
| 1 | M | 16 | 52.5 | Staphylococcus aureus | 53 | Rifampicin, Cefuroxime, Cotrimoxazole. |
| 2 | M | 15 | 73.5 | Staphylococcus epidermidis multi-resistant | 52.5 | Cefuroxime, Rifampicin, Ciprofloxacin. |
| 3 | M | 8 | 65.5 | Staphylococcus epidermidis multi-resistant | 51 | NA |
| 4 | L | 14 | NA | Enterobacter cloacae | 49.5 | Cefuroxime, Ciprofloxacin, Rifampicin. |
| 5 | M | 12 | 87 | Staphylococcus aureus | 47 | Rifampicin, Cefuroxime, Cotrimoxazole. |
| 6 | M | 12 | 243 | Streptococcus mitis | 46 | Rifampicin, Ciprofloxacin, Clindamycin. |
| 7 | L | 50 | 154 | Staphylococcus epidermidis | 43 | Rifampicin, Vancomycin, Flucloxacillin. |
| 8 | L | 19 | 2.5 | Streptococcus mitis, Streptococcus oralis | 34.5 | Cefuroxime, Rifampicin, Ciprofloxacin, Clindamycin. |
| 9 | M | 12 | 95 | Staphylococcus aureus | 33.5 | Ciprofloxacin, Rifampicin. |
| 10 | M | 16 | 2.5 | Staphylococcus aureus, staphylococcus epidermidis | 28 | Cefuroxime, Cotrimoxazole. |
| 11 | M | 55 | 89 | Staphylococcus epidermidis | 27.5 | Ciprofloxacin, Rifampicin. |
| 12 | M | 33 | 119 | Staphylococcus epidermidis, Staphylococcus coagulase negative, Corynebacterium. | NA | Cefuroxime, Rifampicin, Ciprofloxacin. |
| 13 | L | 22 | 25 | Staphylococcus aureus | 24 | Cefuroxime, Rifampicin, Amoxicillin/Clavulanic Acid. |
| 14 | M | 16 | 171 | Staphylococcus capitis, Staphylococcus epidermidis | 22.5 | Rifampicin, Cefuroxime, Ciprofloxacin. |
| 15 | M | 11 | 75.9 | Staphylococcus epidermidis | 18 | Rifampicin, Vancomycin, Cotrimoxazole. |
| 16 | M | 22 | 18.5 | Acinetobacter baumannii complex | 16 | Vancomycin, Rifampicin, Ampicillin/Sulbactam, Cotrimoxazole. |
| 17 | M | 37 | 111 | Staphylococcus epidermidis | 14 | Rifampicin, Flucloxacillin. |
| 18 | M | 34 | 58 | Staphylococcus aureus | 13 | Rifampicin, Vancomycin, Cotrimoxazole. |
| 19 | L | 15 | 233 | Staphylococcus aureus, Enterococcus faecalis | 11.5 | Vancomycin, Rifampicin, Amoxicillin/Clavulanic Acid. |
CRP: C-Reactive Protein; DAIR: Debridement, Antibiotics and Implant Retention; L: Lateral; M: Medial; NA: Not Available/Applicable; UKA: Uni-compartmental Knee Arthroplasty.